Serum albumin level as prognostic indicator of acute ischemic stroke in tertiary care hospital admitted patients


  • Prafulla Kumar Dash Department of Radiodiagnosis, Kalinga Institute of Medical Science, Bhubaneswar, Odisha, India
  • Smrutiranjan Behera Department of Medicine, SCB Medical College, Cuttack, Odisha, India
  • Nirmal Chandra Sahoo Department of Medicine,SCB Medical College, Cuttack, Odisha, India
  • Roma Rattan Department of Biochemistry, SCB Medical College, Cuttack, Odisha, India
  • Saroj Kumar Tripathy Department of Medicine, SCB Medical College, Cuttack, Odisha, India



Acute ischemic stroke, NIHSS score, mRS score, Serum albumin


Background: Serum Albumin level is an important multifunctional protein in the blood for maintaining the normal permeability across vessel wall by osmotic gradient, in inhibiting platelet aggregation and in reducing blood viscosity.  Serum albumin level as a novel parameter for predicting outcome and assessment of severity of coronary artery disease is established. Keeping in mind the scarcity of studies regarding albumin level in ischemic Cerebrovascular Accident (CVA), present study was undertaken to correlate serum albumin level with clinical outcome in acute ischemic stroke (AIS) patients.

Methods: One hundred patients of diagnosed AIS were included in the study. Thorough clinical examination and risk factor profile assessment was done. Severity of stroke was assessed using National Institute of Health Stroke Scale (NIHSS) Score and then followed up to 1 week and 3 months post-admission with serum albumin level and assessment was done using modified Rankin Scale (mRS) score. Institutional ethics committee cleared the study.

Results: In 100 patients with AIS, 58% were male and 42% were female. Mean age was 65±8.160. Motor weakness (85%) was the commonest presenting symptom. Around 75% of patients revealed infarction in middle cerebral artery (MCA) territory. Hypertension (HTN) (74%) was the most frequently associated comorbid condition. Patients with low serum albumin level at admission time were directly proportional to severity of stroke at presentation and poor clinical outcome. 1 week and 3 months follow up mean albumin level (g/dl) was 3.8±0.25 and 3.7±0.23 in patients with poor functional outcome respectively. Significant co-relation between mean serum albumin level and clinical outcome was observed.

Conclusions: Serum albumin level is inversely correlated with severity of stroke at presentation and functional outcome in patients on follow up.


Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;48:439-58.

WHO. Stroke, Cerebrovascular accident [Internet]. Health topics. 2013. Available at: Accessed 28 November 2019.

Buckley BM. Healthy ageing: ageing safely. European Heart Journal Supplements. 2001:3(N):N6-10.

Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007 Feb;6 (2):182-7.

Cucchira BL, Kasner SE, wolk DA. Early impairment in consciousness predicts mortality after hemispheric ischemic stroke. Crit care Med. 2004:32(1):241-5.

Belayev L, Liu Y, Zhao W, Busto R, Ginsberg MD. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke. 2001;32:553-60.

Roche M, Rondeau P, Singh NR. The antioxidant properties of serum albumin. FEBS Lett. 2008; 582:1783-7.

Belayev L. The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats. Brain Res. 1998; 804:105-13.

Miquel J, Johnson JE Jr, Cervos-Navarro J. Comparison of CNS aging in humans and experimental animals. In: Cervos-Navarro J, Sarkander HI, eds. Brain Aging: Neuropathology and Neuropharmacology (Aging, Vol 21). New York, NY: Raven Press Publishers; 1983;231-258.

Ginsberg MD. The albumin in Acute Stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke. 2011;42:119-27.

Don BR, Kaysen G. Poor nutritional status and inflammation: serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004; 17:432-7.

Gariballa. Influence of nutritional status on clinical outcome after acute stroke. Am J Clin Nutr. 1998;68:275-81.

Babu MS, Kaul S, Dadheech S, Rajeshwar K, Jyothy A, Munshi A. Serum albumin levels in ischemic stroke and its subtypes: correlation with clinical outcome. Nutrition. 2013;29(6):872-5.

Ramesh VG. Bedside computed tomography in traumatic brain injury. Neurol India 2016. 2019; 64:12-3.

James R, Antony J, Sreedhar S, Mathew R, Surendran A. study of serum albumin as a predictor of short-term functional outcome in acute ischaemic stroke J. Evolution Med Dent Sci. 2278-4802.

Kasundra G, Sood I. Prognostic Significance Of Serum Albumin Levels In Acute Ischemic Stroke. Natl J Integr Res Med. 2014;5:1-4.

Prasad BO, Sunita T, Kauser U. Acute ischemic stroke in young adults-a hospital based study in North India. Int J Biomed Research. 2015;6:113-7.

Dziedzic T, Slowik A, Szczudlik A. Serum albumin level as a predictor of ischemic stroke outcome. Stroke. 2004 Jun 1;35(6):e156-8.






Original Research Articles